Table 2.
Independent predictors of survival in patients with thymic carcinomas and thymic neuroendocrine tumors adjusted for multivariable Cox proportional hazard analysis
| Variable | Hazard ratio | 95% CI | P value |
|---|---|---|---|
| VATS (ref = open) | 0.46 | 0.19, 1.11 | 0.084 |
| Age (per year) | 1.03 | 1.00, 1.06 | 0.041 |
| Male (ref = female) | 1.08 | 0.57, 2.04 | 0.819 |
| ECOG (ref = 0) | |||
| 1 | 1.04 | 0.53, 2.06 | 0.905 |
| 2 | 2.18 | 0.92, 5.17 | 0.076 |
| Tumor size (per cm) | 0.97 | 0.85, 1.11 | 0.696 |
| Masaoka-Koga stage (ref = stage I–IIA) | |||
| IIB | 1.41 | 0.26, 7.51 | 0.689 |
| III | 4.72 | 1.08, 20.64 | 0.039 |
| IV | 9.57 | 2.06, 44.42 | 0.004 |
| TNET (ref = TC) | 0.92 | 0.38, 2.23 | 0.857 |
| Length of stay(day), Median (IQR) | 1.00 | 0.96, 1.03 | 0.870 |
| level I care(day), Median (IQR) | 1.02 | 0.93, 1.12 | 0.708 |
| Intraoperative bleeding(ml), Median (IQR) | 1.00 | 1.00, 1.00 | 0.325 |